(Q79079828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00541.X

13 March 2024

author name string

Syria Laperche

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Pascal Morel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Marie Deschaseaux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Françoise Bouchardeau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Gulie Alimardani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Nicolas Guillaume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Philippe Rouger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Jean-Jacques Lefrère

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14507275

13 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1537-2995.2003.00541.x

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00541.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1537-2995.2003.00541.x

13 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00541.X

13 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1428-1432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

International application of the incidence rate/window period model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Estimated risk of transfusion-transmitted viral infections in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Sensitivity of HCV RNA and HIV RNA blood screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00541.X

A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity

21 January 2018

15

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00541.X

Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping

13 March 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00541.X

NAT update: where are we today?

13 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00541.X

Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: current research perspectives

13 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00541.X

13 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14507275%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference